Semler Scientific, Inc.
SMLR
$28.12
$0.030.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -43.19% | -44.44% | -17.56% | -17.19% | -22.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -43.19% | -44.44% | -17.56% | -17.19% | -22.25% |
| Cost of Revenue | -41.12% | -24.86% | 21.23% | 4.05% | 2.95% |
| Gross Profit | -43.39% | -46.11% | -20.05% | -18.74% | -24.02% |
| SG&A Expenses | 29.19% | 21.28% | -13.67% | -14.41% | -23.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.67% | 14.10% | -10.61% | -10.31% | -20.22% |
| Operating Income | -138.37% | -119.37% | -31.00% | -26.57% | -25.49% |
| Income Before Tax | 6,985.58% | -1,060.23% | 1,057.64% | -8.77% | -85.17% |
| Income Tax Expenses | 1,110.48% | -689.73% | 339.52% | -48.03% | -36.99% |
| Earnings from Continuing Operations | 608,381.82% | -1,165.40% | 591.92% | 1.72% | -99.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 608,381.82% | -1,165.40% | 591.92% | 1.72% | -99.81% |
| EBIT | -138.37% | -119.37% | -31.00% | -26.57% | -25.49% |
| EBITDA | -136.67% | -118.25% | -30.84% | -27.06% | -24.18% |
| EPS Basic | 356,606.25% | -865.25% | 486.07% | -3.01% | -99.82% |
| Normalized Basic EPS | 4,628.41% | -506.44% | 371.50% | -19.88% | -87.47% |
| EPS Diluted | 359,814.29% | -964.44% | 534.57% | 1.41% | -99.81% |
| Normalized Diluted EPS | 4,515.57% | -558.88% | 402.58% | -15.47% | -86.91% |
| Average Basic Shares Outstanding | 68.87% | 39.22% | 18.06% | 4.88% | 3.54% |
| Average Diluted Shares Outstanding | 72.99% | 23.30% | 10.76% | -0.60% | -0.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |